finance.yahoo.com
La Jolla Pharmaceutical Company Appoints Darryl Wellinghoff as Chief Commercial Officer
La Jolla Pharmaceutical Company (LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced the appointment of Darryl Wellinghoff as Chief Commercial Officer